Karriereverlauf von Karen B. Chapman
Ehemalige bekannte Positionen von Karen B. Chapman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCOCYTE CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2011 | 22.03.2017 |
Origen Therapeutics, Inc.
 Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Gründer | - | - |
Ausbildung von Karen B. Chapman
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Cornell University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Health Technology |
- Börse
- Insiders
- Karen B. Chapman
- Erfahrung
